Neonatal Urine Screening Program in the Province of Quebec: Technological Upgrade from Thin Layer Chromatography to

Christiane Auray-Blais1, Michel Boutin1, Pamela Lavoie1

  • 1Division of Medical Genetics, Department of Pediatrics, Centre de Recherche-CHUS, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.

Insights

The Quebec Neonatal Urine Screening Program successfully screens over 3.5 million newborns for metabolic disorders. A new mass spectrometry method enhances detection of treatable genetic diseases in infants.

Area of Science:

  • Medical Genetics
  • Biochemistry
  • Public Health

Background:

  • The Quebec Neonatal Urine Screening Program, established in 1971, screens newborns for inborn errors of metabolism.
  • Over 3.5 million infants have been screened for up to 25 metabolic disorders since 1973.
  • The program aims to detect treatable diseases before clinical symptoms arise.

Purpose of the Study:

  • To evaluate the feasibility of upgrading the screening technology to mass spectrometry.
  • To develop and validate a rapid mass spectrometry assay for neonatal urine screening.

Main Methods:

  • A 2.85-minute flow injection method using mass spectrometry was developed.
  • Normal values were established, and abnormal profiles were confirmed with second-tier tests.
  • Urine specimens from 21-day-old infants were analyzed.

Main Results:

  • The validated mass spectrometry assays demonstrated sensitivity and specificity for populational and high-risk screening.
  • The method successfully identified Triple H syndrome in an affected patient's urine, a condition not detected by standard newborn blood screening.
  • High compliance rates (~90%) were maintained throughout the program's history.

Conclusions:

  • Mass spectrometry is a feasible and effective technological upgrade for neonatal urine screening.
  • The enhanced screening method improves the detection of treatable inborn errors of metabolism, including those missed by traditional methods.
  • This advancement supports early diagnosis and intervention for genetic disorders in newborns.

Related Concept Videos

Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
7.5K
Tandem Mass Spectrometry01:21

Tandem Mass Spectrometry

Tandem mass spectrometry is a technique that uses multiple mass analyzers in series to obtain a higher selectivity and signal-to-noise ratio for the analyte. Instruments with multiple analyzers separated by an interaction cell enable secondary fragmentation and selected study of the fragment ions.
Secondary fragmentations occur in the interaction cell and can be induced by various factors. Fragmentation induced by collision with inert gases, such as N2, Ar, He, etc., is called collision-induced...
1.8K
MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
6.0K